-
G286872-5mgGSK 591 dihydrochloride.
-
G288263-10mgInactive isomer ofGSK J4: cell permeable.
-
G288263-50mgInactive isomer ofGSK J4: cell permeable.
-
G287870-100mgProduct description:A cell-permeable, reversible, ATP-competitive, and tricyclic, benzofurano-indazolo compound that acts as a potent and specific inhibitor of class III receptor tyrosine kinases (IC50 = 300 nM for c-fms, c-kit, wt-FLT3, and
-
G287870-10mgProduct description:A cell-permeable, reversible, ATP-competitive, and tricyclic, benzofurano-indazolo compound that acts as a potent and specific inhibitor of class III receptor tyrosine kinases (IC50 = 300 nM for c-fms, c-kit, wt-FLT3, and
-
G287870-25mgProduct description:A cell-permeable, reversible, ATP-competitive, and tricyclic, benzofurano-indazolo compound that acts as a potent and specific inhibitor of class III receptor tyrosine kinases (IC50 = 300 nM for c-fms, c-kit, wt-FLT3, and
-
G287870-50mgProduct description:A cell-permeable, reversible, ATP-competitive, and tricyclic, benzofurano-indazolo compound that acts as a potent and specific inhibitor of class III receptor tyrosine kinases (IC50 = 300 nM for c-fms, c-kit, wt-FLT3, and
-
G287870-5mgProduct description:A cell-permeable, reversible, ATP-competitive, and tricyclic, benzofurano-indazolo compound that acts as a potent and specific inhibitor of class III receptor tyrosine kinases (IC50 = 300 nM for c-fms, c-kit, wt-FLT3, and
-
G287074-10mgSelective inhibitor of OXE-R Gβ/γsignaling.
-
G287074-50mgSelective inhibitor of OXE-R Gβ/γsignaling.
-
Ab175978-10mgGuinea Pig IgG Antibody: Isotype Control Antibody.
-
Ab175978-1mgGuinea Pig IgG Antibody: Isotype Control Antibody.